ultrainnovative – Tackle rare and dynamic challenges
Ultragenyx is preparing for the potential commercialization of a rare disease Antisense oligonucleotide therapy for the treatment of Angelman Syndrome. We are seeking a highly analytical, collaborative MBA Intern to support global launch readiness with a specific focus on Phase 3 (Ph3) data–driven scenario planning. This role will help design and execute workstreams and trigger-based plans that activate when Ph3 data become available. For example, the intern may lead pressure-testing a comprehensive plan to update the forecast, value proposition, Target Product Profile (TPP), positioning, and developing and testing core messages under different data readout scenarios (e.g., positive primary endpoint, mixed/secondary strength, subgroup effects).
Remote: Officially documented as working full-time from home, with travel to Ultragenyx's offices or other locations on occasion as needed.
U.S. Hourly Wage Range:
#LI-AJ1 #LI-Remote
Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status, and any other status or classification protected by applicable federal, state, and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law, including individuals with disabilities, disabled veterans, for pregnancy, childbirth, and related medical conditions, and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or in any part of the recruitment process, you may contact Talent Acquisition by emailing us at talentacquisition@ultragenyx.com.
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.